11172017Headline:

Dallas-Fort Worth, Texas

HomeTexasDallas-Fort Worth

Email Shezad Malik MD JD Shezad Malik MD JD on LinkedIn Shezad Malik MD JD on Twitter Shezad Malik MD JD on Facebook Shezad Malik MD JD on Avvo
Shezad Malik MD JD
Shezad Malik MD JD
Attorney • (888) 210-9693

Nuvaring Pulmonary Embolism and Deep Vein Thrombosis Risk Update

Comments Off

As a Texas medical doctor and Dallas product liability, defective drug injury and wrongful death attorney I am providing this timely update for folks who have been injured by the use of Nuvaring contraceptive drugs. Many wrongful death victims are seeking compensation for their injuries from Merck and Organon, the maker of Nuvaring drugs.

Recently, U.S. District Judge Rodney W. Sippel, who is overseeing the Nuvaring litigation, has denied Organon motion to keep certain key documents under seal.

NuvaRing Pulmonary Embolism and Deep Vein Thrombosis

NuvaRing Pulmonary Embolism and Deep Vein Thrombosis injury lawsuits filed in the federal court system have been consolidated before Judge Sippel for centralized pretrial proceedings in the U.S. District Court for the Eastern District of Missouri. All of the cases involve claims that women suffered serious and sometimes deadly, blood clots from side effects of NuvaRing.

NuvaRing Earliest Federal Trial Dates Set for May 2013

A small group of test lawsuits, known as bellwether cases, have been set for early trial dates in the federal NuvaRing multidistrict litigation. The first NuvaRing federal trial date will begin on May 6, 2013, and the plaintiff is a 33 year old woman who suffered a pulmonary embolism while using the birth control ring.

The outcome of the early trial dates in the litigation are useful for the parties to determine how the juries are to respond to the lawsuits. If the plaintiffs are successful in their claims, a positive outcome will help pave the way to a global settlement. But, if NuvaRing settlements are not reached in these cases, the court may begin remanding cases back to federal district courts throughout the country for individual trials.

What is Nuvaring?

NuvaRing is a birth control device that releases female hormones through a plastic ring that is inserted into the vagina once a month. The ring releases estrogen ethinyl estradiol, and a “third-generation” progestin, known as etonogestrel. These hormones have been linked to an increased risk of blood clots and thrombotic events, such as pulmonary embolism, deep vein thrombosis, stroke and sudden death.

Read more here and visit our website for further information.